Small Cap Voice

Greg P. Bell, Chairman & CEO of B2Digital (Pink Sheets: BTDG) Incorporated (the “Company”), called into SmallCapVoice.com, Inc. to go over the business model for the Company , the recent milestones for the company in 2019, and the operational goals for the remainder of 2019. Recently, BTDG announced today that it has acquired Pinnacle Combat of Iowa. The acquisition is effective immediately. Pursuant to the terms of the acquisition agreement, B2Digital acquired 100% of the equity interests in Pinnacle Combat for a combination of cash and shares of B2Digital’s restricted common stock.

With extensive background in entertainment, television, video and technology, the Company is now forging ahead and becoming a full-service Live Event Sports Company. The Chairman and CEO of the company at the helm is Greg P. Bell. Capitalizing on the combination of his expertise, relationships and experience as well as his involvement with more than 40,000 LIVE events over his career for major sports leagues and entertainment venues, B2 Digital is in the process of developing and acquiring MMA and sports related companies to become a Premier Vertically Integrated LIVE Event Sports Company. B2’s first strategy is to build an integrated Premier Development League for the MMA Mixed Martial Arts marketplace, which is a billion-dollar industry.

B2 Digital will be creating and developing Development League champions that will move on to the MMA Major Leagues from the B2 Fighting Series. In 2017 B2 started operating B2FS LIVE MMA Events and each year the top fighters will be invited to the yearly B2FS National Championship Live Event. B2 owns all rights for TV, Internet, Social Media, media, merchandising and trademarks and branding for the B2 Digital Companies. B2 has deployed its B2 Social Media Network digital distribution network for the B2 Fighting Series and has developed and deployed the Systems and Technologies for the operation of Social Media Marketing, Event Management, Digital Ticketing Sales, Digital Video Distribution, Digital Marketing, PPV, Fighter Management, Merchandise Sales, Brand Management and Financial Control Systems.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $1,900 from a third party on behalf of the issuer on 8-21-19 for 30 days of service.

Jean Martineau President and CEO of Dynacor Gold Mines, Inc. (TSX: DNG / Pink Sheets: DNGDF) called in to SmallCapVoice.com, Inc. to go over the business model for the Corporation, the recent milestones for the company in 2019, and the operational goals for the remainder of 2019. Recently Dynacor announced for the three-month period ended June 30, 2019, Dynacor completed its thirty third (33rd) consecutive quarter of profits with a net income of $0.8 M ($0.02 per share), compared to $1.3 M ($0.03 per share) for the same period of 2018. This is the 33rd consecutive quarter of profits.

Dynacor is a dividend paying gold production corporation headquartered in Montreal, Canada. The corporation is engaged in production through the processing of ore purchased from small scale artisanal miners. At present, Dynacor produces and explores in Peru where its management team has decades of experience and expertise. In 2018, Dynacor produced 81,314 ounces of gold, a yearly best and 1.8% increase as compared with 2017 (79,897 ounces).

Dynacor produces environmental and socially responsible gold through its ‘’PX Impact’’ gold program. A growing number of supportive firms from the fine luxury jewelry, watchmakers and investment sectors are paying a small premium to our customer and strategic partner for this PX Impact gold. The premium provides direct investment to develop health and education projects to our small-scale artisanal miner's communities.

Dynacor trades on the Toronto Stock Exchange (DNG) and the OTC in the United States under the symbol (DNGDF).

This interview may include forward looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $950 from the company on 8-16-19 for 30 days of service.

Jean Martineau President and CEO of Dynacor Gold Mines, Inc. (TSX: DNG / Pink Sheets: DNGDF) called in to SmallCapVoice.com, Inc. to go over the business model for the Corporation, the recent milestones for the company in 2019, and the operational goals for the remainder of 2019. Recently Dynacor announced for the three-month period ended June 30, 2019, Dynacor completed its thirty third (33rd) consecutive quarter of profits with a net income of $0.8 M ($0.02 per share), compared to $1.3 M ($0.03 per share) for the same period of 2018. This is the 33rd consecutive quarter of profits.

Dynacor is a dividend paying gold production corporation headquartered in Montreal, Canada. The corporation is engaged in production through the processing of ore purchased from small scale artisanal miners. At present, Dynacor produces and explores in Peru where its management team has decades of experience and expertise. In 2018, Dynacor produced 81,314 ounces of gold, a yearly best and 1.8% increase as compared with 2017 (79,897 ounces).

Dynacor produces environmental and socially responsible gold through its ‘’PX Impact’’ gold program. A growing number of supportive firms from the fine luxury jewelry, watchmakers and investment sectors are paying a small premium to our customer and strategic partner for this PX Impact gold. The premium provides direct investment to develop health and education projects to our small-scale artisanal miner’s communities.

Dynacor trades on the Toronto Stock Exchange (DNG) and the OTC in the United States under the symbol (DNGDF).

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $950 from the company on 8-16-19 for 30 days of service.

Marc Hazout of SusGlobal Energy Corp. (OTCQB: SNRG) called in to SmallCapVoice.com, Inc. to go over the business model for the Company, the recent milestones for the company in 2019, and the operational goals for the remainder of 2019.

SusGlobal Energy Corp., the developer of SusGro™, a revolutionary pathogen-free organic liquid fertilizer is a renewables company focused on acquiring, developing and monetizing a portfolio of proprietary technologies in the waste to energy and regenerative products application globally. It is management's objective to grow SusGlobal into a significant sustainable waste to energy and regenerative products provider, as Leaders in The Circular Economy™. For more information, please visit the Company's website at: www.susglobalenergy.com

This interview may include forward looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $2,500 from the Company on 8-6-19 for 30 days of service.

Marc Hazout of SusGlobal Energy Corp. (OTCQB: SNRG) called in to SmallCapVoice.com, Inc. to go over the business model for the Company, the recent milestones for the company in 2019, and the operational goals for the remainder of 2019.

SusGlobal Energy Corp., the developer of SusGro™, a revolutionary pathogen-free organic liquid fertilizer is a renewables company focused on acquiring, developing and monetizing a portfolio of proprietary technologies in the waste to energy and regenerative products application globally. It is management’s objective to grow SusGlobal into a significant sustainable waste to energy and regenerative products provider, as Leaders in The Circular Economy™. For more information, please visit the Company’s website at: www.susglobalenergy.com

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $2,500 from the Company on 8-6-19 for 30 days of service.

On this call Medical Marijuana, Inc. (Pink Sheets: MJNA) CEO Dr. Stuart Titus and COO Blake Schroeder provide updates on the financial and operational performance of the Company in the second quarter of 2019, share recent research and development progress, and discuss where the company is headed for the remainder of the year and in the future.

Second Quarter 2019 Financial and Operating Highlights

Record revenue of $20.7 million in the second quarter of 2019, a 30.8% increase over the same quarter in 2018;

13 of 14 quarters of sequential revenue growth;

Generated $1.4 million of cash from operations, with total cash balance increasing to $5.4 million at quarter end;

Gross Profit of $15.4 million in the second quarter of 2019, a 61% increase over the same quarter in 2018;

Adjusted EBITDA of $1.5 million in the second quarter of 2019, an increase of 129% over the same quarter in 2018;

Cost of Goods Sold decreased as a percentage of sales from 39% in Q2 of 2018 to 26% in Q2 of 2019, resulting in gross profit margins increasing 74% as compared to 60% in Q2 2018;

General & Administrative expenses decreased from 21% of sales in Q2 2018 to 16% of sales revenue in Q2 of 2019;

Net Ordinary Income for the period was $877,964; compared to a LOSS of $2 million in the same period last year;

The Company's CEO Dr. Stuart Titus was chosen as one of 65 speakers to present oral comments at the U.S. Food & Drug Administration (FDA)'s public hearing discussing products containing cannabis-derived compounds;

Subsidiary Kannaway® was recognized by Direct Selling News as one of the top revenue-generating direct selling companies on the 2019 DSN Global 100 list;

Subsidiary Kannaway®, was named the winner of a Gold Stevie® Award in the Medium Company of the Year – Health Products & Services category in The 17th Annual American Business Awards®;

The Company reached a major milestone for long-term stability testing on its flagship THC-free cannabidiol (CBD) oil product Real Scientific Hemp Oil-X™ (RSHO-X™);

Subsidiary Kannaway® began pre-marketing initiatives in Japan ahead of significant expected growth.

"We are excited to continue our tremendous sequential success with the second quarter of 2019 proving to be the largest sales revenue quarter in the history of our Company," said Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, Inc. "As the world continues to become more receptive to learning about the benefits of hemp-derived CBD, we are enthusiastic about being at the forefront of the global cannabis industry which, according to Arcview Market Research, could be worth $57 billion by 2027."

Operating Results – Q2 2019 Compared to Q2 2018

Sales for the second quarter of 2019 exceeded $20.6 million, an increase of more than 30% over Q2 2018. Second quarter sales growth reflects the Company's international and domestic expansion into all sales channels, including direct-to-consumer, wholesale and direct selling channels.

The Company reported net ordinary income of $877,964 in the second quarter of 2019, compared to a LOSS of $2 million in the second quarter of the prior year.

The Company executed on a strategic profitability and sales growth plan that resulted in gross margins increasing from 61% in Q2 of 2018 to 74% in Q2 of 2019 as well as decreased General & Administrative Expenses as they relate to percentage of sales revenue.

"We hope that these impressive results excite our valued shareholders and look forward to providing more transparency and accountability moving forward," said Medical Marijuana, Inc. COO Blake Schroeder. "Our number one priority is profitability and we are not only reaching our quarterly goals for this but are surpassing them."

Non-GAAP Adjusted EBITDA for the second quarter of 2019 was $1.5 million or 7.4% of net revenue, compared to $0.7 million or 4.2% of net revenue, in the second quarter of 2018.

Finally, the Company generated $1.9 million of cash flow, with total cash balance increasing to $5.4 million at quarter end.

Financial Data: Q2 2019 Compared to Q2 2018 Numbers

Gross Revenue:

Q2 2019 – $20.7 million

Q2 2018 – $15.8 million

Cost of Goods Sold:

Q2 2019 – $5.3 million, which represents 25.7% of sales 

Q2 2018 – $6.2 million, which represents 39.5% of sales

Gross Profit:

Q2 2019 – $15.3 million

Q2 2018 – $9.6 million

Gross Margin:

Q2 2019 – 74.3%

Q2 2018 – 60.6%

Sales & Marketing Expense (includes direct selling commissions):

Q2 2019 – $10.9 million, which represents 53% of sales

Q2 2018 – $8.2 million, which represents 52% of sales

General & Administrative Expense:

Q2 2019 – $3.5 million, which represents 16.9% of sales

Q2 2018 – $3.4 million, which represents 21.6% of sales

Net Ordinary Income/(Loss):

Q2 2019 – $.09 million

Q2 2018 – ($2.0 million)

Net Income/(Loss):

Q2 2019 – ($15.0 million)

Q2 2018 – ($21.1 million)

Disclaimer: SmallCapVoice.com, Inc. received $875 from a third party on behalf of the issuer on 8-18-18 for 30 days of service.

On this call Medical Marijuana, Inc. (Pink Sheets: MJNA) CEO Dr. Stuart Titus and COO Blake Schroeder provide updates on the financial and operational performance of the Company in the second quarter of 2019, share recent research and development progress, and discuss where the company is headed for the remainder of the year and in the future.

Second Quarter 2019 Financial and Operating Highlights

* Record revenue of $20.7 million in the second quarter of 2019, a 30.8% increase over the same quarter in 2018;

* 13 of 14 quarters of sequential revenue growth;

* Generated $1.4 million of cash from operations, with total cash balance increasing to $5.4 million at quarter end;

* Gross Profit of $15.4 million in the second quarter of 2019, a 61% increase over the same quarter in 2018;

* Adjusted EBITDA of $1.5 million in the second quarter of 2019, an increase of 129% over the same quarter in 2018;

* Cost of Goods Sold decreased as a percentage of sales from 39% in Q2 of 2018 to 26% in Q2 of 2019, resulting in gross profit margins increasing 74% as compared to 60% in Q2 2018;

* General & Administrative expenses decreased from 21% of sales in Q2 2018 to 16% of sales revenue in Q2 of 2019;

* Net Ordinary Income for the period was $877,964; compared to a LOSS of $2 million in the same period last year;

* The Company’s CEO Dr. Stuart Titus was chosen as one of 65 speakers to present oral comments at the U.S. Food & Drug Administration (FDA)’s public hearing discussing products containing cannabis-derived compounds;

* Subsidiary Kannaway® was recognized by Direct Selling News as one of the top revenue-generating direct selling companies on the 2019 DSN Global 100 list;

* Subsidiary Kannaway®, was named the winner of a Gold Stevie® Award in the Medium Company of the Year – Health Products & Services category in The 17th Annual American Business Awards®;

* The Company reached a major milestone for long-term stability testing on its flagship THC-free cannabidiol (CBD) oil product Real Scientific Hemp Oil-X™ (RSHO-X™);

* Subsidiary Kannaway® began pre-marketing initiatives in Japan ahead of significant expected growth.

“We are excited to continue our tremendous sequential success with the second quarter of 2019 proving to be the largest sales revenue quarter in the history of our Company,” said Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, Inc. “As the world continues to become more receptive to learning about the benefits of hemp-derived CBD, we are enthusiastic about being at the forefront of the global cannabis industry which, according to Arcview Market Research, could be worth $57 billion by 2027.”

Operating Results – Q2 2019 Compared to Q2 2018

Sales for the second quarter of 2019 exceeded $20.6 million, an increase of more than 30% over Q2 2018. Second quarter sales growth reflects the Company’s international and domestic expansion into all sales channels, including direct-to-consumer, wholesale and direct selling channels.

The Company reported net ordinary income of $877,964 in the second quarter of 2019, compared to a LOSS of $2 million in the second quarter of the prior year.

The Company executed on a strategic profitability and sales growth plan that resulted in gross margins increasing from 61% in Q2 of 2018 to 74% ...

“The Company has evolved tremendously this year.” stated S. Parikh Mars, CEO. “I am looking forward to discussing the financial results over the last quarter, but more importantly, laying out the context for our development this year and the plan for future growth.”

This call consists of a review of the current financial statement, and overall business update, and a questions and answers session including questions submitted by the shareholders.

Progressive Care Inc. (RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.

RXMD: SmallCapVoice.com, Inc. received $2,500 from the company on 12-14-17 for 30 days of service. SmallCapVoice.com, Inc. received $2,500 from the company on 2-1-18 for 30 days of service. SmallCapVoice.com, Inc. received $2,500 from the company on 3-1-18 for 30 days of service. SmallCapVoice.com, Inc. received $2,500 from the company on 4-1-18 for 30 days of service. SmallCapVoice.com, Inc. received $2,500 from the company on 5-1-18 for 30 days of service. SmallCapVoice.com, Inc. received $2,500 from the company on 6-1-18 for 30 days of service. SmallCapVoice.com, Inc. receives $2,500 monthly from the company monthly beginning on 6-1-18 through 11-30-18 for investor relations services. SmallCapVoice.com, Inc. received $1,000 from the company on 12-3-18 for 15 days of service. SmallCapVoice.com, Inc. received $5,000 from the company on 1-9-19 for 30 days of service. SmallCapVoice.com, Inc. received $5,000 from the company on 2-9-19 for 30 days of service. SmallCapVoice.com, Inc. received $5,000 from the company on 3-9-19 for 30 days of service. SmallCapVoice.com, Inc. received $5,000 from the company on 4-9-19 for 30 days of service. SmallCapVoice.com, Inc. received $875 from the Company on 5-7-19 to host their quarterly conference call. SmallCapVoice.com, Inc. received $5,000 from the company on 7/5/19 for 30 days of service.

“The Company has evolved tremendously this year.” stated S. Parikh Mars, CEO. “I am looking forward to discussing the financial results over the last quarter, but more importantly, laying out the context for our development this year and the plan for future growth.”

This call consists of a review of the current financial statement, and overall business update, and a questions and answers session including questions submitted by the shareholders.

Progressive Care Inc. (RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.

RXMD: SmallCapVoice.com, Inc. received $2,500 from the company on 12-14-17 for 30 days of service. SmallCapVoice.com, Inc. received $2,500 from the company on 2-1-18 for 30 days of service. SmallCapVoice.com, Inc. received $2,500 from the company on 3-1-18 for 30 days of service. SmallCapVoice.com, Inc. received $2,500 from the company on 4-1-18 for 30 days of service. SmallCapVoice.com, Inc. received $2,500 from the company on 5-1-18 for 30 days of service. SmallCapVoice.com, Inc. received $2,500 from the company on 6-1-18 for 30 days of service. SmallCapVoice.com, Inc. receives $2,500 monthly from the company monthly beginning on 6-1-18 through 11-30-18 for investor relations services. SmallCapVoice.com, Inc. received $1,000 from the company on 12-3-18 for 15 days of service. SmallCapVoice.com, Inc. received $5,000 from the company on 1-9-19 for 30 days of service. SmallCapVoice.com, Inc. received $5,000 from the company on 2-9-19 for 30 days of service. SmallCapVoice.com, Inc. received $5,000 from the company on 3-9-19 for 30 days of service. SmallCapVoice.com, Inc. received $5,000 from the company on 4-9-19 for 30 days of service. SmallCapVoice.com, Inc. received $875 from the Company on 5-7-19 to host their quarterly conference call. SmallCapVoice.com, Inc. received $5,000 from the company on 7/5/19 for 30 days of service.

GrowLife, Inc. Reports Over $4.4m in Revenue in First Six Months of 2019 Compared to $4.6m in Revenue for ALL of 2018

Summary

GrowLife reports gross revenue of $2.2 million as compared to revenue of $1.2 million for the same period in 2018, an increase of 82%

GrowLife reports gross profit for the six-month period ending on June 30, 2019 of $1.4 million, compared to $187,900 in the same period last year, representing a 669% increase

GrowLife focused product profitability in Q2 of 2019, which resulted in gross margin increases to over 30% from 9% for the same period last year, an increase of 232%

GrowLife continues to experience growth due to the successful integration of recently acquired EZ-CLONE Enterprises, Inc. and increased demand for cloning products for use in hemp CBD products.

KIRKLAND, Wash. , Aug. 12, 2019 (GLOBE NEWSWIRE) -- GrowLife, Inc. (OTC: PHOT) (“GrowLife” or the “Company”), one of the nation’s most recognized indoor cultivation product and service providers, today announced financial results for the period ending June 30, 2019, and provided an overview of recent operational highlights from that quarter and the first half of 2019. The company experienced surging growth over last year, showing an 82% increase in revenue over Q2 2018, from $1.2 million to over $2.2 million in Q2 2019. Additionally, the company continued to make significant progress towards profitability, reporting $1.4m in gross profit for the six month period ending June 30, 2019, a 669% increase over the same period last year. This was due to a major shift in profit margins, which increased to 31% in Q2 2019 compared to just 9% in Q2 2019.

“Beyond almost triple-digit revenue growth and almost surpassing last year's revenue in just the first half of this year, I could not be more proud of the team’s performance that led to an increase in our gross profit of over 600% year-over-year,” said GrowLife CEO Marco Hegyi. “As we continue to shift from a   commodity business to a full-scale manufacturer of the industry’s leading cloning solution, our margins continue to increase and we continue to focus on profitability. As the cannabis industry, and more specifically the hemp-CBD market continues to experience explosive growth across the globe, GrowLife is extremely well-positioned to take advantage of this market opportunity through our innovative cloning product offering. This is illustrated in the fact that our revenue for the first six months of this year represents nearly all revenue generated in 2018.”

“As we look to bring further innovation in cultivation technologies, we utilized this quarter to continue to invest and build out manufacturing capacity in order to meet our increasing backlog of orders as well as the further growing demand for the EZ-CLONE product line. We are extremely confident that through our strategic investment in EZ CLONE, we have positioned ourselves very well to capitalize on these expanding market opportunities. Where EZ CLONE was able to create a quality product with steady growth, GrowLife has propelled it into an international brand being utilized by some of the largest grow operations in the world.”

SECOND QUARTER 2019 FINANCIAL RESULTS

Net Revenue: For the period ending June 30, 2019, GrowLife showed net revenue of $2.2 million as compared to revenue of $1.2 million for the period that ended June 30, 2018, an increase of 82%.

Gross Profit: For the period ending June 30, 2019, GrowLife showed gross profit of $675,773 as compared to revenue of $111,481 for the period that ended June 30, 2018, an increase of 506%.

Gross Profit Margin: Gross Profit Margin, expressed as a percentage of the difference between revenue and cost of goods sold divided by revenue, was 30.71% for the period ending on June 30, 2019, compared to 9.23% for the period ending June 20, 2018, an increase of 232%.

SECOND QUARTER 2019 OPERATIONAL HIGHLIGHTS

During Q2 2019, GrowLife, Inc. achieved the following milestones and significant events:

FINANCIAL HEALTH OF COMPANY

GrowLife, Inc. Reported Over $2.2M in Revenue in Q1 2019, Up 216% Year-Over-Year, and Increased Gross Margins to Over 34% from 10% Last Year

GrowLife experienced revenue growth of 216% year-over-year and reports gross revenue of $2,244,279, as compared to revenue of $708,936 for the same period in 2018

PARTNERSHIP AGREEMENTS

GrowLife, Inc. Announced Partner Agreement with Cannabis Technology Company to add Spectral Imagery to EZ-CLONE Systems

GrowLife added spectral imagery technology to EZ-CLONE’s Pro commercial propagation system, enabling cultivators to analyze plants in the system for overall health and potential disease

Emerald Metrics was granted a provisional patent for its Clone Imaging System

PATENT ISSUANCE

GrowLife, Inc. Received Patent Issuance on Commercial Cloning System Designed for Hemp and Cannabis Industries

GrowLife received the patent for the design of its EZ-CLONE Pro Commercial Cloning System, “Aeroponics System with Rack and Tray”

LAUNCH OF NEW PLATFORM

GrowLife, Inc. Launched Hemp Focused EZ-CLONE Platform to Serve as Leading Industrial Hemp Cloning Resource

The company officially launched the EZ-CLONE platform as an all-encompassing resource for cultivators

SALES EVENTS AND TRADESHOWS 

GrowLife, Inc. Exhibited at CannaCon in Rapidly Expanding Cultivation Market of Oklahoma

GrowLife announced its participation as an exhibitor at the CannaCon on April 19, 2019, in Oklahoma City, a state where there were 100,672 patient applications and 4,820 business applications received in the state

GrowLife, Inc. Presented at the Planet MicroCap Showcase 2019 in Las Vegas

GrowLife presented at Las Vegas’s Planet MicroCap Showcase on May 1, 2019

Company representatives demonstrated how the GrowLife is filling the growing demand for cannabis and hemp products and discussed the EZ-CLONE Pro commercial propagation system and its benefits

GrowLife, Inc. Showcased its Product at MJBizConNEXT in New Orleans

GrowLife was an exhibitor at the MJBizConNEXT in New Orleans from June 12-14, 2019

Company representatives met with other industry professionals at the event

GrowLife shared information about how cloning plants can reduce production costs by an estimated 20%

GrowLife, Inc. Announced Presenting Sponsorship of Inaugural CannGrow Expo in Expanding Oklahoma Market

GrowLife participated in the first-ever CannGrow Expo from October 17-19, 2019

Executives from both GrowLife and EZ-CLONE hosted panels and sessions on best practices in cloning hemp and marijuana plants

GrowLife representatives shared insight on how to best utilize cloning and propagation technologies to render healthier and larger plants

For more information about GrowLife, please visit the company’s website. Products can be purchased at ShopGrowLife.com. Additional commentary on the company and the industry as a whole can be found on the CEO’s blog.

About GrowLife, Inc.

GrowLife, Inc. (PHOT) aims to become the nation’s largest cultivation service provider for cultivating organics, herbs and greens and plant-based medicines. Our mission is to help make our customers successful. Through a network of local representatives covering the United States and Canada, regional centers and its e-Commerce team, GrowLife provides essential goods and services including media, industry-leading hydroponics and soil, plant nutrients, and thousands more products to specialty grow operations. GrowLife is headquartered in Kirkland, Washington and was founded in 2012.

For more information, The GrowLife 2018 Stockholder Review presentation can be found on the Company’s homepage at www.GrowLifeInc.com.

Public Relations Contact:

CMW Media

Cassandra Dowell, 858-264-6600

www.cmwmedia.com

Investor Relations Contact:

FORWARD LOOKING STATEMENT:

This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of GrowLife, Inc., its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words may, would, will, expect, estimate, can, believe, potential and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond GrowLife, Inc.’s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors. SmallCapVoice.com, Inc. received $875 from a third party on behalf of the issuer on 8-12-18 for 30 days of service.